Polycystic Ovary Syndrome Latest Advances

Maternal polycystic ovary syndrome and the risk of neurodevelopmental disorders in preterm neonates.

Journal: Pediatric endocrinology, diabetes, and metabolism

Published: September 07, 2026

DRP-1 and circadian rhythms: deciphering their impact on PCOS.

Journal: Chronobiology international

Published: September 07, 2026

Ovulation induction versus artificial cycles in women with polycystic ovary syndrome: a retrospective cohort study.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Published: September 07, 2026

Personalized approach to infertility treatment in a patient with polyendocrine metabolic ovarian syndrome and chronic pancreatitis.

Journal: Ceska gynekologie

Published: September 07, 2026

Expert consensus for the evaluation and treatment of androgen excess in women

Journal: Zhonghua fu chan ke za zhi

Published: September 07, 2026

Polycystic Ovary Syndrome Prediction Using Machine Learning: A Comparative Analysis of Classification Algorithms.

Journal: EJIFCC

Published: September 05, 2026

Enhanced behavioral responses to ghrelin administration are unaffected by ghrelin deficiency in a DHT-induced PCOS mouse model.

Journal: American journal of physiology. Endocrinology and metabolism

Published: September 04, 2026

Impaired Epidermal Renewal and Dermal Collagen Disorganization in a Dehydroepiandrosterone-Induced Mouse Model of Polycystic Ovary Syndrome.

Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Published: September 04, 2026

Integrated multi-omics analyses identify an RAS-SLC11A2-associated molecular framework linking iron metabolism with PCOS-related cardiometabolic risk.

Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)

Published: September 01, 2026

Polycystic Ovary Syndrome and Cardiovascular Risk: Mechanisms, Clinical Evidence, and Prevention Strategies.

Journal: Cardiology in review

Published: August 31, 2026

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk.

Journal: Journal of internal medicine

Published: August 30, 2026

Lycopus lucidus Extract Improves Experimental Polycystic Ovary Syndrome with Gut Microbiota and Metabolome Remodeling.

Journal: Journal of visualized experiments : JoVE

Published: August 29, 2026

Polycystic Ovary Syndrome Latest Advances

Find the Latest Research About Polycystic Ovary Syndrome

Maternal polycystic ovary syndrome and the risk of neurodevelopmental disorders in preterm neonates.

Maternal polycystic ovary syndrome and the risk of neurodevelopmental disorders in preterm neonates.

DRP-1 and circadian rhythms: deciphering their impact on PCOS.

DRP-1 and circadian rhythms: deciphering their impact on PCOS.

Ovulation induction versus artificial cycles in women with polycystic ovary syndrome: a retrospective cohort study.

Ovulation induction versus artificial cycles in women with polycystic ovary syndrome: a retrospective cohort study.

Personalized approach to infertility treatment in a patient with polyendocrine metabolic ovarian syndrome and chronic pancreatitis.

Personalized approach to infertility treatment in a patient with polyendocrine metabolic ovarian syndrome and chronic pancreatitis.

Expert consensus for the evaluation and treatment of androgen excess in women

Expert consensus for the evaluation and treatment of androgen excess in women

Polycystic Ovary Syndrome Prediction Using Machine Learning: A Comparative Analysis of Classification Algorithms.

Polycystic Ovary Syndrome Prediction Using Machine Learning: A Comparative Analysis of Classification Algorithms.

Enhanced behavioral responses to ghrelin administration are unaffected by ghrelin deficiency in a DHT-induced PCOS mouse model.

Enhanced behavioral responses to ghrelin administration are unaffected by ghrelin deficiency in a DHT-induced PCOS mouse model.

Impaired Epidermal Renewal and Dermal Collagen Disorganization in a Dehydroepiandrosterone-Induced Mouse Model of Polycystic Ovary Syndrome.

Impaired Epidermal Renewal and Dermal Collagen Disorganization in a Dehydroepiandrosterone-Induced Mouse Model of Polycystic Ovary Syndrome.

Integrated multi-omics analyses identify an RAS-SLC11A2-associated molecular framework linking iron metabolism with PCOS-related cardiometabolic risk.

Integrated multi-omics analyses identify an RAS-SLC11A2-associated molecular framework linking iron metabolism with PCOS-related cardiometabolic risk.

Polycystic Ovary Syndrome and Cardiovascular Risk: Mechanisms, Clinical Evidence, and Prevention Strategies.

Polycystic Ovary Syndrome and Cardiovascular Risk: Mechanisms, Clinical Evidence, and Prevention Strategies.

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk.

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk.

Lycopus lucidus Extract Improves Experimental Polycystic Ovary Syndrome with Gut Microbiota and Metabolome Remodeling.

Lycopus lucidus Extract Improves Experimental Polycystic Ovary Syndrome with Gut Microbiota and Metabolome Remodeling.